期刊
CANCER CELL
卷 28, 期 3, 页码 296-306出版社
CELL PRESS
DOI: 10.1016/j.ccell.2015.07.014
关键词
-
资金
- NIH [R21CA167229, UL1 RR024153, UL1TR000005, 1P50 CA097190, T32 GM075770]
- Roswell Park Cancer Institute/University of Pittsburgh Cancer Institute Ovarian Cancer Specialized Programs of Research Excellence [P50CA159981]
- National Natural Science Foundation of China (NSFC) [31428005, 31320103918, 81273208]
- 973 grant [2013CB530501]
Cytokines play a pivotal role in regulating tumor immunogenicity and antitumor immunity. IL-36 gamma is important for the IL-23/IL-17-dominated inflammation and anti-BCG Th1 immune responses. However, the impact of IL-36 gamma on tumor immunity is unknown. Here we found that IL-36 gamma stimulated CD8(+) T cells, NK cells, and gamma delta T cells synergistically with TCR signaling and/or IL-12. Importantly, IL-36 gamma exerted profound antitumor effects in vivo and transformed the tumor microenvironment in favor of tumor eradication. Furthermore, IL-36 gamma strongly increased the efficacy of tumor vaccination. Moreover, IL-36 gamma expression inversely correlated with the progression of human melanoma and lung cancer. Our study establishes a role of IL-36 gamma in promoting antitumor immune responses and suggests its potential clinical translation into cancer immunotherapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据